4[3]National Committee for Clinical Laboratory Standards. Methods for dilution anti-microbial susceptibility tests for bacteria that grow aerobically-fourth edition; Approved standard[S]. NCCLS,1997,M7-A4,Vol.17,No.2.
5[4]National Committee for Clinical Laboratory Standards. Performance standards for anti-microbial disc susceptibility tests-sixth edition; Approved standard[S]. NCCLS,1997,M2-A6,Vol.17,No.1.
6Cockerill FR 3rd,Smith TF. Response of the clinical microbiology laboratory to emerging (new) and reemerging infectious diseases. J Clin Microbiol, 2004, 42: 2359-2365.
7Infectious Diseases Society of America. Policy statement on consolidation of clinical microbiology laboratories. Clin Infect Dis, 2001, 32: 604.
8Boyce N. The health care systems′ changing climate. Clinical Laboratory News, 1996, 22:10.
9Peterson LR, Hamilton JD, Baron EJ, et al. Role of clinical microbiology laboratories in the management and control of infectious diseases and the delivery of health care. Clin Infect Dis, 2001, 32: 605-611.
10Hinman AR. Global progress in infectious disease control. Vaccine, 1998,16 :1116-1121.
